Results 201 to 210 of about 170,643 (213)

Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies

Clinical Pharmacokinetics, 2017
A. Marsot, R. Guilhaumou, C. Riff, O. Blin   +3 more
semanticscholar   +1 more source

Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial*

Critical Care Medicine, 2018
N. Hassan, F. F. Awdallah, Maggie M. Abbassi, N. Sabry   +3 more
semanticscholar   +1 more source

Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients.

Journal of Global Antimicrobial Resistance, 2018
J. Ruiz, P. Ramírez, M. Company, M. Gordon, E. Villarreal, P. Concha, M. Aroca, J. Frasquet, María Remedios-Marqués, Á. Castellanos‐Ortega   +9 more
semanticscholar   +1 more source

Amikacin

Reactions Weekly, 2010
openaire   +2 more sources

Amikacin

Reactions Weekly, 2019
openaire   +2 more sources

Amikacin⋆

Reactions, 1986
openaire   +1 more source

Amikacin

Reactions Weekly, 2020
openaire   +1 more source

A simplified guide for charged aerosol detection of non‐chromophoric compounds—Analytical method development and validation for the HPLC assay of aerosol particle size distribution for amikacin

Journal of Pharmaceutical and Biomedical Analysis, 2017
A. Soliven, Imad A. Haidar Ahmad, J. Tam, N. Kadrichu, P. Challoner, R. Markovich, A. Blasko   +6 more
semanticscholar   +1 more source

Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2005
exaly  

Amikacin.

American family physician, 1977
openaire   +1 more source